Anti-PD-1 antibody-activated TILs (Sun Yat-Sen University)

抗PD1抗体激活的自体肿瘤浸润淋巴细胞（中山大学）

Report date: 2026/04/17 10:36:29

Base Information

Drug NameAnti-PD-1 antibody-activated TILs (Sun Yat-Sen University)

Drug Alias NameAnti-Programmed Cell Death Protein 1(Anti-PD1) Antibody-activated Autologous Tumor Infiltrating Lymphocytes (TILs)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionLymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesSun Yat-Sen University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSun Yat-Sen University

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms

Other Information

ATC CodeN/A